Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 189 entries
View as:

A Study to Investigate the Effect of Severe Renal Impairment on Gilteritinib Compared to Healthy Participants With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT04699877 Org: User:
Start: 01/28/21 End: 07/18/22 Due: 07/18/23

A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

Phase: N/A Priority: Normal
NCT ID: NCT03653507 Org: User:
Start: 11/28/18 End: 09/30/25 Due: 09/30/26

A Study of ASP1951 in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03799003 Org: User:
Start: 01/14/19 End: 07/06/23 Due: 07/06/24

A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT03241550 Org: User:
Start: 10/02/17 End: 07/05/19 Due: 07/05/20

Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis

Phase: N/A Priority: Normal
NCT ID: NCT00815516 Org: User:
Start: 02/28/13 End: 12/31/14 Due: 12/31/15

A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03356639 Org: User:
Start: 01/22/18 End: 05/30/18 Due: 05/30/19

Study of the Effect of Repeat Doses of Isavuconazole on Cardiac Repolarization

Phase: N/A Priority: Normal
NCT ID: NCT01565720 Org: User:
Start: 03/31/12 End: 06/30/12 Due: 06/30/13

Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants

Phase: N/A Priority: Normal
NCT ID: NCT04939701 Org: User:
Start: 12/23/21 End: 06/01/23 Due: 06/01/24

An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04136808 Org: User:
Start: - End: - Due: -

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06440967 Org: User:
Start: 07/31/24 End: 09/30/28 Due: 09/30/29

A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction

Phase: N/A Priority: Normal
NCT ID: NCT04855201 Org: User:
Start: 06/14/21 End: 12/16/22 Due: 12/16/23

A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT02997202 Org: User:
Start: 08/16/17 End: 05/09/23 Due: 05/09/24

Drug Interaction Study of Isavuconazole and Digoxin

Phase: N/A Priority: Normal
NCT ID: NCT01582412 Org: User:
Start: 03/31/12 End: 05/31/12 Due: 05/31/13

Drug Interaction Study of Isavuconazole and Methadone

Phase: N/A Priority: Normal
NCT ID: NCT01582425 Org: User:
Start: 04/30/12 End: 06/30/12 Due: 06/30/13

A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body

Phase: N/A Priority: Normal
NCT ID: NCT01529684 Org: User:
Start: 03/19/12 End: 02/20/13 Due: 02/20/14

Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT03421002 Org: User:
Start: 05/30/15 End: 04/10/18 Due: 04/10/19

A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study

Phase: N/A Priority: Normal
NCT ID: NCT03042013 Org: User:
Start: 02/28/17 End: 02/28/17 Due: 02/28/18

A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02059590 Org: User:
Start: 04/30/13 End: 04/30/13 Due: 04/30/14

A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause

Phase: N/A Priority: Normal
NCT ID: NCT04003389 Org: User:
Start: 07/10/19 End: 01/04/22 Due: 01/04/23

A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2

Phase: N/A Priority: Normal
NCT ID: NCT04003142 Org: User:
Start: 07/10/19 End: 04/23/21 Due: 04/23/22

A Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Tablet Formulation and Pediatric Azo Dye-free Mini-tablet Formulation Compared to a Single Dose of Azo Dye-containing Tablet Formulation in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03960489 Org: User:
Start: 07/31/19 End: 10/14/19 Due: 10/14/20

A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03565445 Org: User:
Start: 07/02/18 End: 03/27/23 Due: 03/27/24

A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01663415 Org: User:
Start: 08/31/12 End: 10/31/14 Due: 10/31/15

A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT03730012 Org: User:
Start: 06/19/19 End: 06/15/21 Due: 06/15/22

A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04447287 Org: User:
Start: 06/29/20 End: 11/25/20 Due: 11/25/21